Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New compounds interacting with 5-HT1 receptors reported by Pfizer

Aug. 29, 2000

Scientists uncover vital role of activin A in neuroprotection after brain injury

Aug. 29, 2000

CRF antagonists from DuPont reportedly useful in depression, etc.

Aug. 28, 2000

Opioid receptor ligands under study at Pfizer

Aug. 28, 2000

Identification of dual Na+/Ca2+ blocker with antioxidant activity reported by Suntory

Aug. 28, 2000

Sigma-1 and sigma-2 receptor ligands developed

Aug. 28, 2000

Morphine tolerance inhibited by metabotropic group II receptor agonists

Aug. 25, 2000

Neuronal cells safely transplanted in stroke patients

Aug. 25, 2000

Neurobiological Technologies and UC, Berkeley sign option agreement for CRF analogues

Aug. 24, 2000

Kyorin receives patent for new series of AMPA antagonists

Aug. 23, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...